SPONSOR
Shanghai Pulmonary Hospital, Shanghai, China
Total Trials
4
Recruiting
4
Phases
Phase 2
Conditions studied: Small-cell Lung CancerThymic CarcinomaNon-small Cell Lung CancerResidual Neuromuscular Block
Shanghai Pulmonary Hospital, Shanghai, China is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Small-cell Lung Cancer, Thymic Carcinoma, Non-small Cell Lung Cancer, Residual Neuromuscular Block.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Pulmonary Hospital, Shanghai, China
How many clinical trials has Shanghai Pulmonary Hospital, Shanghai, China sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Shanghai Pulmonary Hospital, Shanghai, China, of which 4 are actively recruiting participants. These trials cover conditions including Small-cell Lung Cancer, Thymic Carcinoma, Non-small Cell Lung Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Pulmonary Hospital, Shanghai, China research focus on?
Shanghai Pulmonary Hospital, Shanghai, China clinical trials span Small-cell Lung Cancer, Thymic Carcinoma, Non-small Cell Lung Cancer, Residual Neuromuscular Block. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Pulmonary Hospital, Shanghai, China clinical trial?
To participate in a Shanghai Pulmonary Hospital, Shanghai, China trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Pulmonary Hospital, Shanghai, China trials with current recruitment status updated daily.
Clinical Trials by Shanghai Pulmonary Hospital, Shanghai, China
NCT04539977 Phase 2
Recruiting
PD-L1 Antibody (TQB2450) Plus Chemotherapy for Previously Untreated Limited- Stage Small-cell Lung Cancer
Small-cell Lung Cancer
NCT06019468 Phase 2
Recruiting
Neoadjuvant Treatment For Locally Advanced Thymic Cancer
Thymic Carcinoma
NCT07328945
Recruiting
Patient-derived Tumor-like Cell Cluster Model-based Precision Treatment Strategy on Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
NCT07309393
Recruiting
Impact of Sugammadex Versus Neostigmine on Early Postoperative Pulmonary Function
Residual Neuromuscular Block
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology